Pavel Khrimian active positions
Companies | Position | Start | End |
---|---|---|---|
Deka Biosciences, Inc.
Deka Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Deka Biosciences, Inc. is a biotech company based in Germantown, MD. Deka Biosciences is committed to developing and delivering life-changing medicines to patients with cancer and inflammatory diseases. The company has developed disease-specific diakines™ that are designed to maximize patient benefits through improved pharmacokinetics/pharmacodynamics function by the targeted accumulation of dual and complimentary cytokines into affected tissues. Deka Biosciences aims to build specific targeted therapies for everyone by developing a better understanding of each patient's immune response to different diakines™. The company was founded in 2019 by John B. Mumm and Pavel Khrimian, with John B. Mumm serving as the CEO since then. | Founder | 01/01/2019 | - |
Corporate Officer/Principal | 01/01/2019 | - |
Career history of Pavel Khrimian
Statistics
International
United States | 2 |
Operational
Founder | 1 |
Corporate Officer/Principal | 1 |
Sectoral
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
Deka Biosciences, Inc.
Deka Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Deka Biosciences, Inc. is a biotech company based in Germantown, MD. Deka Biosciences is committed to developing and delivering life-changing medicines to patients with cancer and inflammatory diseases. The company has developed disease-specific diakines™ that are designed to maximize patient benefits through improved pharmacokinetics/pharmacodynamics function by the targeted accumulation of dual and complimentary cytokines into affected tissues. Deka Biosciences aims to build specific targeted therapies for everyone by developing a better understanding of each patient's immune response to different diakines™. The company was founded in 2019 by John B. Mumm and Pavel Khrimian, with John B. Mumm serving as the CEO since then. | Health Technology |
- Stock Market
- Insiders
- Pavel Khrimian
- Experience